BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Barozzi A, Lavoie RA, Day KN, Prodromou R, Menegatti S. Affibody-Binding Ligands. Int J Mol Sci 2020;21:E3769. [PMID: 32471034 DOI: 10.3390/ijms21113769] [Cited by in Crossref: 3] [Cited by in F6Publishing: 1] [Article Influence: 1.5] [Reference Citation Analysis]
Number Citing Articles
1 Tchekwagep PMS, Crapnell RD, Banks CE, Betlem K, Rinner U, Canfarotta F, Lowdon JW, Eersels K, van Grinsven B, Peeters M, Mcclements J. A Critical Review on the Use of Molecular Imprinting for Trace Heavy Metal and Micropollutant Detection. Chemosensors 2022;10:296. [DOI: 10.3390/chemosensors10080296] [Reference Citation Analysis]
2 Chu W, Prodromou R, Moore B, Elhanafi D, Kilgore R, Shastry S, Menegatti S. Development of Peptide Ligands for the Purification of α-1 Antitrypsin from Cell Culture Fluids. Journal of Chromatography A 2022. [DOI: 10.1016/j.chroma.2022.463363] [Reference Citation Analysis]
3 Xiao X, Kilgore R, Sarma S, Menegatti S, Hall CK. De novo Discovery of Peptide-based Affinity Ligands for the Fab Fragment of Human Immunoglobulin G. Journal of Chromatography A 2022. [DOI: 10.1016/j.chroma.2022.462941] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
4 Lwin TM, Turner MA, Amirfakhri S, Nishino H, Hoffman RM, Bouvet M. Fluorescence Molecular Targeting of Colon Cancer to Visualize the Invisible. Cells 2022;11:249. [DOI: 10.3390/cells11020249] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
5 Skottrup PD, Døssing H, Andersen NW, Buch-Rasmussen L. Nanobody-based microfluidic human Fc assay for preclinical plasma quantification of IgG1/1.1 and IgG1-Fc-conjugates. J Immunol Methods 2022;502:113214. [PMID: 34998814 DOI: 10.1016/j.jim.2022.113214] [Reference Citation Analysis]
6 Rondon A, Mahri S, Morales‐yanez F, Dumoulin M, Vanbever R. Protein Engineering Strategies for Improved Pharmacokinetics. Adv Funct Mater 2021;31:2101633. [DOI: 10.1002/adfm.202101633] [Cited by in Crossref: 8] [Cited by in F6Publishing: 3] [Article Influence: 8.0] [Reference Citation Analysis]
7 Prodromou R, Day KN, Saberi‐bosari S, Schneible JD, Mabe MD, San Miguel A, Daniele MA, Pozdin V, Menegatti S. Engineering Next Generation Cyclized Peptide Ligands for Light‐Controlled Capture and Release of Therapeutic Proteins. Adv Funct Mater 2021;31:2101410. [DOI: 10.1002/adfm.202101410] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 2.0] [Reference Citation Analysis]
8 Chu W, Prodromou R, Day KN, Schneible JD, Bacon KB, Bowen JD, Kilgore RE, Catella CM, Moore BD, Mabe MD, Alashoor K, Xu Y, Xiao Y, Menegatti S. Peptides and pseudopeptide ligands: a powerful toolbox for the affinity purification of current and next-generation biotherapeutics. J Chromatogr A 2021;1635:461632. [PMID: 33333349 DOI: 10.1016/j.chroma.2020.461632] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]